Short Interest in ViaDerma, Inc. (OTCMKTS:VDRM) Declines By 19.9%

ViaDerma, Inc. (OTCMKTS:VDRM) was the target of a large decrease in short interest in January. As of January 31st, there was short interest totalling 99,600 shares, a decrease of 19.9% from the January 15th total of 124,300 shares. Based on an average daily volume of 5,158,600 shares, the days-to-cover ratio is presently 0.0 days.

ViaDerma Trading Up 4.1 %

OTCMKTS VDRM opened at $0.02 on Friday. ViaDerma has a 1 year low of $0.00 and a 1 year high of $0.02. The company’s 50 day simple moving average is $0.01 and its two-hundred day simple moving average is $0.01.

ViaDerma Company Profile

ViaDerma, Inc operates as a specialty pharmaceutical company in the United States. It focuses on developing and marketing pharmaceutical products, as well as licensing its technology to companies in the pharmaceutical industry in various therapeutic areas. The company’s lead product is Vitastem, a tetracycline-based topical antibiotic used for cuts, scrapes, wounds, infections, burns, acne, psoriasis, eczema, and minor injuries.